Cellectis CLLS
NASDAQ CLLS
$0.97 -0.02 (-2.17%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cellectis (CLLS) Current Leases (2021 - 2022)

Updated

Cellectis' Current Leases came in at $8.39 million for Q4 2023, compared with $97,000 a year earlier.

Analysis

Cellectis (CLLS) Current Leases (2021 - 2022) Analysis & Trends

Going back to Q4 2016, Cellectis' Current Leases data covers 6 quarters.

  • Going back by year, Current Leases was $97,000 in FY2022 (-73.8%) and $370,000 in FY2021.
  • The Q4 2023 figure represents the highest quarterly Current Leases since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Cellectis 98.28 Mn -655.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 97,000.00
Mar 31, 2022 290,000.00
Dec 31, 2021 370,000.00
API Access

Cellectis Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CLLS&period=max&api_key=YOUR_API_KEY